Cargando…

SRSF6 Regulates the Alternative Splicing of the Apoptotic Fas Gene by Targeting a Novel RNA Sequence

SIMPLE SUMMARY: Alternative splicing (AS) produces multiple mRNA isoforms from a gene to make a large number of proteins. Fas (Apo-1/CD95) pre-mRNA, a member of TNF receptor family that mediates apoptosis, can generate pro-apoptotic and anti-apoptotic proteins through AS. Here, we identified SRSF6 a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Namjeong, Jang, Ha Na, Oh, Jagyeong, Ha, Jiyeon, Park, Hyungbin, Zheng, Xuexiu, Lee, Sunjae, Shen, Haihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025165/ https://www.ncbi.nlm.nih.gov/pubmed/35454897 http://dx.doi.org/10.3390/cancers14081990

Ejemplares similares

Relative strength of 5’ splice-site strength defines functions of SRSF2 and SRSF6 in alternative splicing of Bcl-x pre-mRNA
por: Choi, Namjeong, et al.
Publicado: (2021)

Activation of Cryptic 3′ Splice-Sites by SRSF2 Contributes to Cassette Exon Skipping
por: Moon, Heegyum, et al.
Publicado: (2019)

Opposite Roles of Tra2β and SRSF9 in the v10 Exon Splicing of CD44
por: Oh, Jagyeong, et al.
Publicado: (2020)

U2AF65-Dependent SF3B1 Function in SMN Alternative Splicing
por: Choi, Namjeong, et al.
Publicado: (2020)

hnRNP A1 Regulates Alternative Splicing of Tau Exon 10 by Targeting 3′ Splice Sites
por: Liu, Yongchao, et al.
Publicado: (2020)

SRSF2 directly inhibits intron splicing to suppresses cassette exon inclusion
por: Moon, Heegyum, et al.
Publicado: (2017)

SRSF9 Regulates Cassette Exon Splicing of Caspase-2 by Interacting with Its Downstream Exon
por: Ha, Jiyeon, et al.
Publicado: (2021)

Widespread Alternative Splicing Changes in Metastatic Breast Cancer Cells
por: Oh, Jagyeong, et al.
Publicado: (2021)

RRM but not the Asp/Glu domain of hnRNP C(1)/C(2) is required for splicing regulation of Ron exon 11 pre-mRNA
por: Moon, Heegyum, et al.
Publicado: (2019)

Global Alternative Splicing Defects in Human Breast Cancer Cells
por: Oh, Jagyeong, et al.
Publicado: (2021)

SR proteins regulate V(6) exon splicing of CD44 pre-mRNA
por: Loh, Tiing Jen, et al.
Publicado: (2016)

Identification of Regulatory-RNAs for Alternative Splicing of Ron Proto-Oncogene
por: Moon, Heegyum, et al.
Publicado: (2015)

SRSF1-mediated alternative splicing is required for spermatogenesis
por: Lei, Wen-Long, et al.
Publicado: (2023)

Decreased Expression of SRSF2 Splicing Factor Inhibits Apoptotic Pathways in Renal Cancer
por: Kędzierska, Hanna, et al.
Publicado: (2016)

Splicing factor SRSF6 mediates pleural fibrosis
por: Liang, Li-Mei, et al.
Publicado: (2021)

Targeting Splicing Factor SRSF6 for Cancer Therapy
por: She, Wenting, et al.
Publicado: (2021)

SRSF6 balances mitochondrial-driven innate immune outcomes through alternative splicing of BAX
por: Wagner, Allison R, et al.
Publicado: (2022)

SRSF10 is essential for progenitor spermatogonia expansion by regulating alternative splicing
por: Liu, Wenbo, et al.
Publicado: (2022)

Alternative polyadenylation dependent function of splicing factor SRSF3 contributes to cellular senescence
por: Shen, Ting, et al.
Publicado: (2019)

Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage
por: Comiskey, Daniel F., et al.
Publicado: (2015)

Splicing factor Srsf5 deletion disrupts alternative splicing and causes noncompaction of ventricular myocardium
por: Zhang, Xiaoli, et al.
Publicado: (2021)

USP39 promotes hepatocellular carcinogenesis through regulating alternative splicing in cooperation with SRSF6/HNRNPC
por: Zheng, Jingyi, et al.
Publicado: (2023)

Splicing factor SRSF6 promotes hyperplasia of sensitized skin
por: Jensen, Mads A., et al.
Publicado: (2014)

Myelodysplasia-associated mutations in serine/arginine-rich splicing factor SRSF2 lead to alternative splicing of CDC25C
por: Skrdlant, Lindsey, et al.
Publicado: (2016)

Transcriptome analysis of alternative splicing events regulated by SRSF10 reveals position-dependent splicing modulation
por: Zhou, Xuexia, et al.
Publicado: (2014)

LncRNA CRNDE attenuates chemoresistance in gastric cancer via SRSF6-regulated alternative splicing of PICALM
por: Zhang, Feifei, et al.
Publicado: (2021)

DRAK2-SRSF6-regulated RNA alternative splicing is a promising therapeutic target in NAFLD/NASH
por: Dalamaga, Maria, et al.
Publicado: (2021)

The control of alternative splicing by SRSF1 in myelinated afferents contributes to the development of neuropathic pain
por: Hulse, Richard P., et al.
Publicado: (2016)

SRSF3 maintains transcriptome integrity in oocytes by regulation of alternative splicing and transposable elements
por: Do, Dang Vinh, et al.
Publicado: (2018)

Srsf7 Establishes the Juvenile Transcriptome through Age-Dependent Alternative Splicing in Mice
por: Kadota, Yosuke, et al.
Publicado: (2020)

Srsf7 Establishes the Juvenile Transcriptome through Age-Dependent Alternative Splicing in Mice
por: Kadota, Yosuke, et al.
Publicado: (2020)

SRSF6 regulates alternative splicing of genes involved in DNA damage response and DNA repair in HeLa cells
por: Yang, Xiao, et al.
Publicado: (2020)

Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation
por: Jia, Rong, et al.
Publicado: (2019)

Genome-wide analysis of SRSF10-regulated alternative splicing by deep sequencing of chicken transcriptome
por: Zhou, Xuexia, et al.
Publicado: (2014)

SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance
por: Sheng, Junxiu, et al.
Publicado: (2018)

Splicing factor SRSF2-centric gene regulation
por: Li, Kun, et al.
Publicado: (2021)

CircRPAP2 regulates the alternative splicing of PTK2 by binding to SRSF1 in breast cancer
por: Yu, Yunhe, et al.
Publicado: (2022)

hnRNPH1 recruits PTBP2 and SRSF3 to modulate alternative splicing in germ cells
por: Feng, Shenglei, et al.
Publicado: (2022)

A naturally occurring soluble isoform of murine Fas generated by alternative splicing
Publicado: (1995)

SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells
por: Liang, Yang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ko663k2ud18cvm9jia91lmfq90